Theresa Gaffney serves as the primary writer for Morning Rounds, focusing on health care, recent research, and public policy issues, particularly surrounding mental health, gender-affirming care, and the LGBTQ+ community. Contact Theresa via Signal at theresagaff.97.
Stay informed about health and medicine every weekday with STAT’s complimentary newsletter Morning Rounds. Sign up here.
Good day! We’re just one week away from the STAT Summit. I’m looking forward to reconnecting with colleagues in person, indulging in delicious snacks, and witnessing remarkable live journalism. I hope to see you there in Boston!
Former Vaccine Regulator Joins Eli Lilly
Peter Marks, who previously held the top vaccine regulatory position at the FDA, has accepted a role at Eli Lilly, where he will focus on molecule discovery and infectious disease initiatives. His departure from the FDA came after being asked to resign by health secretary Robert F. Kennedy Jr. back in March, as reported by STAT’s Lizzy Lawrence. Marks expressed his enthusiasm for the opportunity to support public health through the advancement of infectious disease products. Read further.
STAT+ Exclusive Content
If you’re already a member, Log in here
This article is available exclusively to STAT+ subscribers
Unlock this piece along with comprehensive analysis, newsletters, premium events, and news alerts.
Already a member? Log in here
-
Theresa Gaffney serves as the primary writer for Morning Rounds, focusing on health care, recent research, and public policy issues, particularly surrounding mental health, gender-affirming care, and the LGBTQ+ community. Contact Theresa via Signal at theresagaff.97.
